力文所完成数千万Pre-A轮融资，为新一代环肽药物的管线开发打开空间

Core Insights - Levinthal Biotech, a leading company in AI protein design, successfully completed a multi-million RMB Pre-A financing round on December 9 [1] - The financing round was led by Jinyumaowu, with Junke Danmu participating, and Zhoudu Capital serving as the exclusive financial advisor [1] - The funds will primarily be used to accelerate the technical iteration of its all-atom model protein design platform, Pallatom, expand its commercial product pipeline, and attract global talent [1] - Pallatom has uniquely addressed the challenge of designing mixed cyclic peptides, paving the way for the development of a new generation of cyclic peptide drugs [1]